Non-type 2 airway inflammation in severe asthma: from bench to bedside
Hiroki Tashiro, Yuki Kuwahara, Yuki Kurihara, Koichiro Takahashi · 2026
Read Non-type 2 airway inflammation in severe asthma: from bench to bedside by Hiroki Tashiro, Yuki Kuwahara, Yuki Kurihara, Koichiro Takahashi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13548123.txt.
Description
Severe asthma that is not driven by the usual allergy pathway is the subject of a 2026 review by Hiroki Tashiro and co-authors. New biologic drugs have tamed the classic type 2 form for many patients, but a large share show a different pattern, often with neutrophil-heavy airways and poor response to steroids.
The review sums up the traits, causes, and candidate targets of this non-type 2 form. Obesity, dirty air, smoking, and chest viruses all feed it. At the cell level, signals such as interleukin-17 switch on pathways that steroids barely touch. The authors chart what is known from lab to clinic and where new treatments might break through.
Catalog record
| CREATOR | Hiroki Tashiro, Yuki Kuwahara, Yuki Kurihara, Koichiro Takahashi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |